HDAX Therapeutics

Next-gen targeting for breakthrough medicines

General Information
Company Name
HDAX Therapeutics
Founded Year
2021
Location (Offices)
Mississauga, Canada +1
Founders / Decision Makers
Number of Employees
15
Industries
Biopharma, Biotechnology, Life Sciences +1
Funding Stage
Grant
Social Media

HDAX Therapeutics - Company Profile

HDAX Therapeutics is a biopharmaceutical and biotechnology startup that was founded in 2021. The company operates within the biopharma, biotechnology, and pharmaceutical industries. Known for its groundbreaking advancements in the field, HDAX Therapeutics received a significant Seed Round investment on September 28, 2022. The investment was made by FACIT, further solidifying the company's position as a promising venture in the biotech sector. With this recent investment, HDAX Therapeutics is poised for rapid growth and substantial contributions to the healthcare and biopharmaceutical industries.

Funding Rounds & Investors of HDAX Therapeutics (2)

View All
Funding Stage Amount No. Investors Investors Date
Grant $500.00K 1 Ministry of Economic Development, Job Creation and Trade 08 Jul 2024
Seed Round Unknown 1 28 Sep 2022

Latest News of HDAX Therapeutics

View All

No recent news or press coverage available for HDAX Therapeutics.

Similar Companies to HDAX Therapeutics

View All
Pioneer Gene - Similar company to HDAX Therapeutics
Pioneer Gene Advancing molecular diagnostics to enhance detection of genetic, tumor, and infectious diseases.
Neuron23 - Similar company to HDAX Therapeutics
Neuron23 We are a biotech company focused on developing precision medicines for neurological and immunological diseases.